| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.3 | 0.1 |